CP

Chaman Pratap Singh

Active Director Director DIN 09402480
DIN 09402480 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Chaman Pratap Singh

Data last updated:

Chaman Pratap Singh is a Director at Shaunit Pharma Private Limited (since 2021). The company operates in Chemicals.

DIN 09402480
Primary Designation Director
Industry Chemicals
First Appointment 17 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shaunit Pharma Private Limited U24290UP2021PTC155584
Director17 Nov 20212021Active

Board colleagues of Chaman Pratap Singh

NameDINCompanyDesignation
Niharika09402481Shaunit Pharma Private LimitedDirector
Ramautar Singh09402482Shaunit Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shaunit Pharma Private Limited
Premium access

Shareholding and investment profile for Chaman Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaman Pratap Singh

Chaman Pratap Singh currently holds 1 directorship: Shaunit Pharma Private Limited (Director, since 17 Nov 2021).

Chaman Pratap Singh was first appointed on 17 Nov 2021 as Director at Shaunit Pharma Private Limited.

The current boards of Chaman Pratap Singh's companies include Niharika (Shaunit Pharma Private Limited), Ramautar Singh (Shaunit Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available